Seeking Alpha

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

LYON, France, March 4, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, announced today that its Focal One platform has been granted Breakthrough Device designation by ...
CNN

EDAP Announces Sale of Robotic Focal One® HIFU Device to University of Miami

LYON, France,January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...
Seeking Alpha

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

LYON, France, January 31, 2022 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced positive clinical results from the Endo-HIFU-R1 Phase 2 study ...
Business Insider

EDAP TMS SA : EDAP Announces the Installation of a Third Focal One® HIFU Device in Brazil

HIFU Prostate Cancer Treatments Successfully Performed at Albert Einstein Hospital, Sao Paulo LYON, France, September 27, 2018 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound ...
Business Insider

EDAP Announces Two Publications Highlighting Favorable HIFU Focal Therapy Outcomes in Journal of Urology

Studies conducted at the University of Southern California and University of Miami represent the first U.S. publications detailing successful partial-gland ablation using high intensity focused ...